Spinal anesthesia showdown: which additive offers better comfort for kidney stone surgery?

NCT ID NCT06957301

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial tests whether adding fentanyl or dexmedetomidine to standard spinal anesthesia improves patient satisfaction and sedation during kidney stone surgery. Sixty adults aged 18–60 undergoing the procedure will receive one of the two combinations. The goal is to find which additive provides better pain control and a smoother recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
fentanyl and dexmedetomidine
What this could lead to
If one combination works better, it could offer a more comfortable and safer anesthesia option for kidney stone surgery.
What could go wrong
This is a small, early-stage trial with only 60 participants, so results may not apply to everyone. Both drugs have known side effects like nausea or low blood pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERCUTANEOUS NEPHROLITHOTOMY (PCNL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Faculty of medicine ,Alexandria university

    Alexandria, Alexandria Governorate, 21521, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.